Literature DB >> 32287601

II, 11. Human adaptive immunity to rotaviruses: A model of intestinal mucosal adaptive immunity.

Ana María Gonzalez1, Maria C Jaimes2,1, Olga L Rojas1, Juana Angel1, Harry B Greenberg2, Manuel A Franco1.   

Abstract

This chapter discusses the human adaptive immune response to rotaviruses (RVs), placing the immune response to RVs in the context of the immune response to other mucosal viruses. The chapter discusses the studies of both RV-specific T and B cells. As children with T and/or B immunodeficiencies can develop chronic RV infection, prolonged symptoms, and extraintestinal infection, it is clear that both T and B cells are important for immunity to RV. The various reasons proposed to explain the absence of complete immunity to mucosal viruses such as RV, following primary infection, include a short incubation period after viral exposure, difficulty in maintaining a high level of protective antibody at respiratory and gastrointestinal mucosal surfaces, and a short-lived protective humoral mucosal immune response.
Copyright © 2003 Published by Elsevier B.V.

Entities:  

Year:  2004        PMID: 32287601      PMCID: PMC7133893          DOI: 10.1016/S0168-7069(03)09018-9

Source DB:  PubMed          Journal:  Perspect Med Virol        ISSN: 0168-7069


  33 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

Authors:  S L Waldrop; C J Pitcher; D M Peterson; V C Maino; L J Picker
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations.

Authors:  W J Rodriguez; H W Kim; C D Brandt; R H Schwartz; M K Gardner; B Jeffries; R H Parrott; R A Kaslow; J I Smith; A Z Kapikian
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

4.  Preponderance of IgM from blood lymphocytes in response to infantile rotavirus gastroenteritis.

Authors:  M Kaila; E Isolauri; E Virtanen; H Arvilommi
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

5.  Systemic lymphoproliferative responses to rotavirus.

Authors:  B M Totterdell; J E Banatvala; I L Chrystie; G Ball; W D Cubitt
Journal:  J Med Virol       Date:  1988-05       Impact factor: 2.327

6.  Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood.

Authors:  B S Coulson; K Grimwood; P J Masendycz; J S Lund; N Mermelstein; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults.

Authors:  María C Jaimes; Olga Lucía Rojas; Ana María González; Isabela Cajiao; Annie Charpilienne; Pierre Pothier; Evelyne Kohli; Harry B Greenberg; Manuel A Franco; Juana Angel
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Chronic enteric virus infection in two T-cell immunodeficient children.

Authors:  D J Wood; T J David; I L Chrystie; B Totterdell
Journal:  J Med Virol       Date:  1988-04       Impact factor: 2.327

9.  Rotavirus-specific helper T cell responses in newborns, infants, children, and adults.

Authors:  P A Offit; E J Hoffenberg; E S Pia; P A Panackal; N L Hill
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

10.  Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG.

Authors:  E Isolauri; J Joensuu; H Suomalainen; M Luomala; T Vesikari
Journal:  Vaccine       Date:  1995-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.